[1]
|
Ullah, A., Khan, J., Waheed, A., Sharma, N., Pryor, E.K., Stumpe, T.R., Zarate, L.V., Cason, F.D., Kumar, S., Misra, S., Kavuri, S., Mesa, H, Roper, N., Foroutan, S., Karki, N.R., Del Rivero, J., Simonds, W.F. and Karim, N.A. (2022) Para-thyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives. Cancers, 14, Article No. 1426. https://doi.org/10.3390/cancers14061426
|
[2]
|
Riley, K. and Anzai, Y. (2022) Imaging of Treated Thyroid and Par-athyroid Disease. Neuroimaging Clinics of North America, 32, 145-157. https://doi.org/10.1016/j.nic.2021.08.014
|
[3]
|
Rezkallah, E., Elsaify, A. and Elsaify, W. (2022) Parathyroid Carci-noma: Case Series Presentation. European Journal of Surgical Oncology, 48, e20. https://doi.org/10.1016/j.ejso.2021.11.088
|
[4]
|
中国研究型医院学会甲状旁腺及骨代谢疾病专业委员会, 中国研究型医院学会罕见病分会. 甲状旁腺癌诊治的专家共识[J]. 中华内分泌代谢杂志, 2019, 35(5): 361-368.
|
[5]
|
Zhao, L., Liu, J.M., He, X.Y., Zhao, H.Y, Sun, L.H, Tao, B., Zhang, M.J., Chen, X., Wang, W.Q. and Ning, G. (2013) The Changing Clinical Patterns of Primary Hyperparathyroidism in Chinese Patients: Data from 2000 to 2010 in a Single Clinical Center. The Journal of Clinical Endocrinology and Metabolism, 98, 721-728.
https://doi.org/10.1210/jc.2012-2914
|
[6]
|
Kowalski, G.J., Bednarczyk, A., Buła, G., Gawrychowska, A. and Gawrychowski, J. (2022) Parathyroid Carcinoma—A Study of 29 Cases. Endokrynologia Polska, 73, 56-63. https://doi.org/10.5603/EP.a2022.0003
|
[7]
|
胡亚, 廖泉. 甲状旁腺癌外科治疗难点问题[J]. 中国实用外科杂志, 2020, 40(5): 508-510.
https://doi.org/10.19538/j.cjps.issn1005-2208.2020.05.06
|
[8]
|
Galata’, G., Hubbard, J., Talat, N., Anscomb, N., Klang, P., Al-Lawati, A., Aldrees, A. and Schulte, K.-M. (2022) Parathyroid Cancer: A Single Centre Experience of the Endocrine Surgical Care Group. British Journal of Surgery, 109, Article ID: znac056-029. https://doi.org/10.1093/bjs/znac056.029
|
[9]
|
Schulte, K.-M. and Talat, N. (2012) Diagnosis and Management of Parathyroid Cancer. Nature Reviews Endocrinology, 8, 612-622. https://doi.org/10.1038/nrendo.2012.102
|
[10]
|
Goldner, E. and Fingeret, A. (2023) Parathyroid Carcinoma: A Na-tional Cancer Database Analysis. Journal of Surgical Research, 281, 57-62. https://doi.org/10.1016/j.jss.2022.08.017
|
[11]
|
Feng, C.Z., Tian, C.W., Huang, L.Y., Chen, H.L., Feng, Y.Q. and Chang, S. (2022) A Bibliometric Analysis of the Landscape of Parathyroid Carcinoma Research Based on the PubMed (2000-2021). Frontiers in Oncology, 12, Article 824201.
https://doi.org/10.3389/fonc.2022.824201
|
[12]
|
Erickson, L.A., Mete, O., Juhlin, C.C., Perren, A. and Gill, A.J. (2022) Overview of 2022 WHO Classification of Parathyroid Tumors. Endocrine Pathology, 33, 64-89. https://doi.org/10.1007/s12022-022-09709-1
|
[13]
|
Swanith, A. (2022) An Overview on Parathyroid Cancer and Diagnosis. Journal of Oncology Research and Treatment, 7.
|
[14]
|
Zhou, Z.K., Shi, Y., Li, C. and Wang, W. (2022) Primary Hyperparathyroidism-Induced Brown Tumors Caused by Parathyroid Carcinoma: A Case Report and Literature Review. Journal of International Medical Research, 50.
https://doi.org/10.1177/03000605221123668
|
[15]
|
Radzikowski, K.C., Rendl, G., Beheshti, M. and Pirich, C. (2022) 18F Choline PET/CT in a Patient with HRPT2 Mutation: Detecting Parathyroid Carcinoma Recurrence and Concomitant Breast Carcinoma. Nuklearmedizin-Nuclear Medicine, 61, 62-64. https://doi.org/10.1055/a-1670-9315
|
[16]
|
Tao, M., Luo, S.Y., Wang, X.M., Jia, M. and Lu, X.B. (2022) A Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study. Frontiers in Endocrinology, 13, Article 850457. https://doi.org/10.3389/fendo.2022.850457
|
[17]
|
Ciregia, F., Cetani, F., Pardi, E., Soggiu, A., Piras, C., Zallocco, L., Borsari, S., Ronci, M., Caruso, V., Marcocci, C., Mazzoni, M.R., Lucacchini, A. and Giusti, L. (2021) Parathyroid Car-cinoma and Adenoma Co-Existing in One Patient: Case Report and Comparative Proteomic Analysis. Cancer Genomics & Proteomics, 18, 781-796.
https://doi.org/10.21873/cgp.20297
|
[18]
|
代文杰, 张爽. 原发性甲状旁腺功能亢进诊治进展[J]. 临床外科杂志, 2018, 26(6): 464-467.
|
[19]
|
Hu, Y., Cui, M., Chang, X.Y., Wang, O., Chen, T.Q., Xiao, J.H., Wang, M.Y., Hua, S.R. and Liao, Q. (2022) Patterns and Predictors of Cervical Lymph Node Metastasis in Parathyroid Carcinoma. Cancers, 14, Article No. 4004.
https://doi.org/10.3390/cancers14164004
|
[20]
|
Campennì, A. and Ruggeri, R.M. (2023) Letter to the Editor: Early Diagnosis of Parathyroid Carcinoma: A Challenging for Physicians. Clinical Endocrinology, 98, 273-274. https://doi.org/10.1111/cen.14807
|
[21]
|
蒋蕾, 周迎生. 甲状旁腺癌伴严重高钙血症1例[J]. 中国实用内科杂志, 2001(4): 213.
|
[22]
|
Kada, S., Tanaka, M. and Yasoda, A. (2021) Parathyroid Carcinoma in a Patient with Secondary Hyperparathyroidism and Thyroid Hemiagenesis: A Case Report and Review of the Literature. Ear, Nose & Throat Journal.
https://doi.org/10.1177/01455613211036240
|
[23]
|
Wei, B.J., Zhao, T., Shen, H., Jin, M.L., Zhou, Q., Liu, X., Wang, J.C. and Wang, Q. (2022) ASO Visual Abstract: Extended En Bloc Reoperation for Recurrent or Persistent Para-thyroid Carcinoma—Analysis of 31 Cases in a Single-Insti- tution Experience. Annals of Surgical Oncology, 29, 1218-1219. https://doi.org/10.1245/s10434-021-11064-0
|